United States News Beep | NewsBeep.com
  • News Beep
  • Breaking News
  • Business
  • Entertainment
  • Health
  • Science
  • Sports
  • Technology
United States News Beep | NewsBeep.com
United States News Beep | NewsBeep.com
  • News Beep
  • Breaking News
  • Business
  • Entertainment
  • Health
  • Science
  • Sports
  • Technology

Browsing Tag

biopharmaceutical company

11 posts
MMedication
FDA Approves Mannkind's At-Home Treatment Option for Heart Failure or Kidney Disease
Read More

FDA Approves Mannkind’s At-Home Treatment Option for Heart Failure or Kidney Disease

  • July 28, 2026
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Mannkind…
MMedication
Cingulate Receives Complete Response Letter from FDA for CTx-1301
Read More

Cingulate Receives Complete Response Letter from FDA for CTx-1301

  • June 5, 2026
Cingulate Inc. No Clinical Safety or Efficacy Concerns Currently Identified Agency Feedback Primarily Focused on CMC-Related RequestsCompany Plans Prompt…
MMedication
Praxis Precision Medicines Announces FDA Acceptance and Priority Review of New Drug Application for Relutrigine in Patients with SCN2A and SCN8A DEEs
Read More

Praxis Precision Medicines Announces FDA Acceptance and Priority Review of New Drug Application for Relutrigine in Patients with SCN2A and SCN8A DEEs

  • March 31, 2026
Praxis Precision Medicines, Inc. FDA assigned PDUFA target action date of September 27, 2026 BOSTON, March 30, 2026…
HHealth care
BioXcel Therapeutics Reports Third Quarter 2025 Financial Results and Provides Update on Late-Stage Clinical Programs for Agitation in Bipolar, Schizophrenia, and Alzheimer’s Disease
Read More

BioXcel Therapeutics Planning to Submit sNDA This Month Seeking FDA Approval for At-Home Use of IGALMI®

  • January 8, 2026
BioXcel Therapeutics Company remains focused on potential approval and launch of IGALMI® for the acute treatment of agitation…
MMental health
Biohaven Provides Update From Phase 2 Proof-of-Concept Study with BHV-7000 in Major Depressive Disorder
Read More

Biohaven Provides Update From Phase 2 Proof-of-Concept Study with BHV-7000 in Major Depressive Disorder

  • December 24, 2025
NEW HAVEN, Conn., Dec. 24, 2025 /PRNewswire/ — Biohaven Ltd. (NYSE: BHVN) (“Biohaven”), a global clinical-stage biopharmaceutical company focused…
MMedication
Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)
Read More

Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)

  • December 19, 2025
Milestone Pharmaceuticals received U.S. Food and Drug Administration approval of CARDAMYST for the conversion of acute symptomatic episodes…
MMarkets
Evaluating Valuation as Healthcare Deal Expands Its AI Platform’s Market Reach
Read More

High Growth Tech Stocks in Asia for October 2025

  • October 13, 2025
As trade tensions between the U.S. and China reignite, impacting global markets, Asian tech stocks continue to capture…
GGenetics
Opus Genetics Appoints Rob Gagnon as Chief Financial Officer
Read More

Opus Genetics Appoints Rob Gagnon as Chief Financial Officer

  • September 2, 2025
Opus Genetics, Inc. Robert Gagnon, CFO, Opus Genetics Robert Gagnon, CFO, Opus Genetics RESEARCH TRIANGLE PARK, N.C., Sept.…
MMarkets
Exploring High Growth Tech Stocks In The US Market
Read More

Exploring High Growth Tech Stocks In The US Market

  • August 12, 2025
As the U.S. stock market navigates a period of volatility, with major indices like the Nasdaq retreating from…
MMarkets
3 Asian Stocks Estimated To Be Up To 40.9% Below Intrinsic Value
Read More

3 Asian Stocks Estimated To Be Up To 40.9% Below Intrinsic Value

  • August 1, 2025
As trade negotiations between major economies progress, Asian markets have shown resilience, with Chinese and Japanese indices posting…
MMarkets
MacroGenics And 2 Other Promising Penny Stocks To Consider
Read More

MacroGenics And 2 Other Promising Penny Stocks To Consider

  • July 14, 2025
Amid a backdrop of trade policy uncertainties and fluctuating market indices, the U.S. stock market remains near record…
United States News Beep | NewsBeep.com
www.newsbeep.com